[Sexual/intimate morbidity under tamoxifen and risk of weakened treatment adherence in premenopausal women with HR+ breast cancer: An underestimated and potentially modifiable factor].

Ancelin F, Bondil P

Open source

DOI
10.1016/j.bulcan.2026.07.018
Published
2026 Sep 24
Container
Bulletin du cancer
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.bulcan.2026.07.018,
  title = {[Sexual/intimate morbidity under tamoxifen and risk of weakened treatment adherence in premenopausal women with HR+ breast cancer: An underestimated and potentially modifiable factor].},
  author = {Ancelin F and Bondil P},
  year = {2026},
  journal = {Bulletin du cancer},
  doi = {10.1016/j.bulcan.2026.07.018},
  url = {https://doi.org/10.1016/j.bulcan.2026.07.018}
}

RIS

TY  - JOUR
TI  - [Sexual/intimate morbidity under tamoxifen and risk of weakened treatment adherence in premenopausal women with HR+ breast cancer: An underestimated and potentially modifiable factor].
AU  - Ancelin F
AU  - Bondil P
PY  - 2026
JO  - Bulletin du cancer
DO  - 10.1016/j.bulcan.2026.07.018
UR  - https://doi.org/10.1016/j.bulcan.2026.07.018
ER  - 

APA

F, A., & P, B. (2026). [Sexual/intimate morbidity under tamoxifen and risk of weakened treatment adherence in premenopausal women with HR+ breast cancer: An underestimated and potentially modifiable factor].. Bulletin du cancer. https://doi.org/10.1016/j.bulcan.2026.07.018

Source records